Hirotoshi Sakaguchi1, Takako Miyamura2, Daisuke Tomizawa3, Takashi Taga4, Hiroyuki Ishida5, Katsuyoshi Koh6, Hiroaki Goto7, Nao Yoshida1, Maho Sato8, Maiko Noguchi9, Junichi Hara10, Masami Inoue8, Yoshiko Hashii2, Yoshiko Atsuta11
(1.Department of Hematology and Oncology, Children’s Medical Center, Japanese red Cross Nagoya First Hospital, Nagoya, Japan, 2.Department of Pediatrics, Osaka University, Suita, Japan, 3.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 4.Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan, 5.Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan, 6.Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan, 7.Division of Hematology/Oncology, Kanagawa Children’s Medical Center, Yokohama, Japan, 8.Department of Hematology/Oncology, Osaka Women’s and Children’s Hospital, Izumi, Japan, 9.Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan, 10.Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan, 11.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)
抄録パスワード認証
パスワードは抄録集の37ページに記載してあります。